Fundraising Fox
Orange Grove Bio
Cincinnati, US · Founded 2019 · Delaware LLC · 29 employees on LinkedIn · 3 known investors
Find your way into Orange Grove Bio
Sign up to see every warm intro you have to Orange Grove Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orange Grove Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Orange Grove Bio is a biotech venture firm that builds and backs cell therapy and immuno-oncology companies, forming subsidiary companies (subcos) such as Ipinovyx and DomainOne Therapeutics. It operates in the biopharmaceutical and life sciences investment space.
Founders & leadership
MK
Michael KalosSenior Venture Partner & Head of Cell TherapyMichael Kalos holds a PhD from the University of Minnesota and completed postdoctoral training at the Fred Hutchinson Cancer Research Center. He spent a decade in academia at the University of Pennsylvania and City of Hope National Medical Center directing translational research laboratories, followed by senior roles at Eli Lilly (Chief Scientific Officer, Immunooncology), Janssen (Vice President, Immuno-Oncology and Oncology Cell Therapies), and ArsenalBio (EVP, Head of R&D), and currently serves as Senior Venture Partner at Orange Grove Bio and Founder and Managing Director of Next Pillar Consulting.
MA
Marc AppelNamed on SEC filing
Investors · 3
AlleyCorplisted by AlleyCorpNew York · $1M – $5M
How we know: AlleyCorp's portfolio page · the VCSheet dataset · Not right? Tell us
__Twitter.png)
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$16.6M disclosed across 1 round · 2022
▶$16.6MraisedAug 2022 · 15 investors · Other Health CareRule 506(b)
▶$16.6MraisedAug 2022 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc AppelExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $16.6M
- First sale
- Aug 2022
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Orange Grove Bio went on to found or lead other companies.
Related companies · 4
Mission BioCapital Platinum Program Holdings LLCMission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.
RelatedRelated Sciences assembles distributed teams of academic experts and industry veterans to conduct specialized drug discovery and research for biotech companies. The company operates a decentralized R&D model where leading scientists work collaboratively on targeted therapeutic programs.
Samsara BiocapitalSamsara BioCapital is a venture capital firm that invests in therapeutic and biotech companies, backing scientific teams developing new drugs and medical treatments.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Companies working in the same space as Orange Grove Bio.
In the news
Frequently asked questions
- What does Orange Grove Bio do?
- Orange Grove Bio is a biotech venture firm that builds and backs cell therapy and immuno-oncology companies, forming subsidiary companies (subcos) such as Ipinovyx and DomainOne Therapeutics. It operates in the biopharmaceutical and life sciences investment space.
- Who are Orange Grove Bio's investors?
- Orange Grove Bio's investors include AlleyCorp, Gaingels, Alley Robotics Ventures.
- How much funding has Orange Grove Bio raised?
- Orange Grove Bio has disclosed $16.6M raised across 1 round.
- Where is Orange Grove Bio headquartered?
- Orange Grove Bio is headquartered in Cincinnati, US.